These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 34293709

  • 1. B-prolymphocytic leukemia: Is it time to retire this entity?
    El Hussein S, Khoury JD, Medeiros LJ.
    Ann Diagn Pathol; 2021 Oct; 54():151790. PubMed ID: 34293709
    [Abstract] [Full Text] [Related]

  • 2. B-cell prolymphocytic leukemia: an enduring bona fide entity.
    Gonzalez-Mancera MS, Lopategui J, Hoffman D, Kitahara S, Alkan S.
    Int J Hematol; 2024 Aug; 120(2):252-255. PubMed ID: 38796826
    [Abstract] [Full Text] [Related]

  • 3. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
    Hoehn D, Miranda RN, Kanagal-Shamanna R, Lin P, Medeiros LJ.
    Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
    [Abstract] [Full Text] [Related]

  • 4. Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment.
    Collignon A, Wanquet A, Maitre E, Cornet E, Troussard X, Aurran-Schleinitz T.
    Curr Oncol Rep; 2017 Apr; 19(4):29. PubMed ID: 28324286
    [Abstract] [Full Text] [Related]

  • 5. Aberrations of MYC are a common event in B-cell prolymphocytic leukemia.
    Flatley E, Chen AI, Zhao X, Jaffe ES, Dunlap JB, Pittaluga S, Abdullah S, Olson SB, Spurgeon SE, Fan G.
    Am J Clin Pathol; 2014 Sep; 142(3):347-54. PubMed ID: 25125625
    [Abstract] [Full Text] [Related]

  • 6. Progression and transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma and B-cell prolymphocytic leukemia: Report from the 2021 SH/EAHP Workshop.
    Czader M, Amador C, Cook JR, Thakkar D, Parker C, Dave SS, Dogan A, Duffield AS, Nejati R, Ott G, Xiao W, Wasik M, Goodlad JR.
    Am J Clin Pathol; 2023 Jun 01; 159(6):554-571. PubMed ID: 37052539
    [Abstract] [Full Text] [Related]

  • 7. De-Novo B-Cell Prolymphocytic Leukemia.
    Menakuru SR, Roepke J, Siddiqui S.
    J Hematol; 2023 Apr 01; 12(2):82-86. PubMed ID: 37187496
    [Abstract] [Full Text] [Related]

  • 8. Development of B-cell prolymphocytic leukemia in a patient with splenic diffuse red pulp small B-cell lymphoma.
    Cheng WY, Zhu YM, Cheng S, Chen YS, Shen Y.
    Leuk Lymphoma; 2018 Aug 01; 59(8):1990-1993. PubMed ID: 29199492
    [No Abstract] [Full Text] [Related]

  • 9. B and T cell prolymphocytic leukaemia.
    Cross M, Dearden C.
    Best Pract Res Clin Haematol; 2019 Sep 01; 32(3):217-228. PubMed ID: 31585622
    [Abstract] [Full Text] [Related]

  • 10. T-cell chronic lymphocytic leukemia or small-cell variant of T-cell prolymphocytic leukemia: a historical perspective and search for consensus.
    Rashidi A, Fisher SI.
    Eur J Haematol; 2015 Sep 01; 95(3):199-210. PubMed ID: 25846234
    [Abstract] [Full Text] [Related]

  • 11. Relapsed B-cell prolymphocytic leukemia (B-PLL) with distinctive granular inclusion bodies.
    Su MY, Chen TC, Teng CJ, Wu CH.
    Int J Lab Hematol; 2024 Aug 01; 46(4):585-586. PubMed ID: 38284307
    [No Abstract] [Full Text] [Related]

  • 12. B-cell prolymphocytic leukemia: a specific subgroup of mantle cell lymphoma.
    van der Velden VH, Hoogeveen PG, de Ridder D, Schindler-van der Struijk M, van Zelm MC, Sanders M, Karsch D, Beverloo HB, Lam K, Orfao A, Lugtenburg PJ, Böttcher S, van Dongen JJ, Langerak AW, Kappers-Klunne M, van Lom K.
    Blood; 2014 Jul 17; 124(3):412-9. PubMed ID: 24891323
    [Abstract] [Full Text] [Related]

  • 13. Auer Rod-Like Inclusions in Prolymphocytic Leukemia.
    Qiufan Z, Shumei X, Xifeng D, Shuwen D, Huaquan W, Zonghong S.
    Clin Lab; 2015 Jul 17; 61(7):831-4. PubMed ID: 26299084
    [Abstract] [Full Text] [Related]

  • 14. Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma.
    Schlette E, Bueso-Ramos C, Giles F, Glassman A, Hayes K, Medeiros LJ.
    Am J Clin Pathol; 2001 Apr 17; 115(4):571-81. PubMed ID: 11293906
    [Abstract] [Full Text] [Related]

  • 15. [Successful treatment of B-cell prolymphocytic leukemia (B-PLL) with FCR-Lite (fludarabine, cyclophosphamide, rituximab) protocol].
    Telek B, Batár P, Rejto L, Udvardy M.
    Orv Hetil; 2010 Aug 01; 151(31):1261-3. PubMed ID: 20656663
    [Abstract] [Full Text] [Related]

  • 16. B-lineage prolymphocytic leukemia as a distinct clinicopathologic entity.
    Katayama I, Aiba M, Pechet L, Sullivan JL, Roberts P, Humphreys RE.
    Am J Pathol; 1980 May 01; 99(2):399-412. PubMed ID: 6929655
    [Abstract] [Full Text] [Related]

  • 17. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.
    Nelson BP, Variakojis D, Peterson LC.
    Mod Pathol; 2002 Nov 01; 15(11):1111-20. PubMed ID: 12429788
    [Abstract] [Full Text] [Related]

  • 18. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. II. Patterns of evolution of 'prolymphocytoid' transformation.
    Melo JV, Catovsky D, Galton DA.
    Br J Haematol; 1986 Sep 01; 64(1):77-86. PubMed ID: 3463362
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.